首页> 外文期刊>Clinical and experimental allergy : >Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I.
【24h】

Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I.

机译:在流行病学研究中要测试的评估过敏原致敏性的过敏原数量:欧洲共同体呼吸健康调查的结果I.

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Many clinical and epidemiological studies have measured the prevalence of IgE sensitization using skin tests and/or serum-specific IgE. Most of them have been done in only one country using a battery of selected allergens relevant to that country. In multi-centre studies, the number of tested allergens is often limited by the cost. It is therefore difficult to compare prevalence of sensitized subjects between studies. OBJECTIVE: To define the number and the type of allergen that should be tested in order to characterize a person as sensitized. METHOD: Subjects were selected from the European Community Respiratory Health Survey I. All subjects underwent skin prick tests to nine of the most common allergens. In addition, two local allergens were tested in some centres. RESULT: Using nine allergens, 35.6% of the 11 355 subjects were sensitized. The prevalence of sensitization increased with the number of tested allergens. Seven allergens enabled the identification of almost all sensitized subjects, adding another one inducing, in most countries, an increase of prevalence under 0.5%. Adding one local allergen to the battery of tests increased the overall estimated prevalence by only 1%. This increase was not seen in Ireland and was less marked in the United Kingdom (0.3%) but was greater in France (2.6%), Australia (2.5%) and Belgium (1.9%). CONCLUSION: Seven selected allergens (Dermatophagoides pteronyssinus, cat, grass, birch, olive pollen, Alternaria and Cladosporium) allow the identification of almost all sensitized subjects in epidemiologic studies. Inclusion of local allergen should be considered in a standard panel for international studies.
机译:背景:许多临床和流行病学研究已经使用皮肤测试和/或血清特异性IgE测量了IgE致敏的患病率。其中大多数是仅在一个国家中使用与该国相关的一系列选定的过敏原而完成的。在多中心研究中,测试的过敏原数量通常受成本限制。因此,很难在研究之间比较敏感受试者的患病率。目的:定义应进行测试的过敏原的数量和类型,以将某人表征为敏感人群。方法:受试者选自欧洲共同体呼吸健康调查I。所有受试者均接受了针对9种最常见过敏原的皮肤点刺测试。此外,在一些中心对两种当地过敏原进行了测试。结果:使用了9种过敏原,在11 355名受试者中有35.6%致敏。致敏率随受试过敏原数量的增加而增加。七种变应原能够鉴定几乎所有的致敏受试者,在大多数国家又增加了另一种,致使患病率增加了0.5%以下。在测试电池组中添加一种局部过敏原只会使总体估计患病率增加1%。在爱尔兰没有看到这种增长,在英国(0.3%)则没有那么明显,而在法国(2.6%),澳大利亚(2.5%)和比利时(1.9%)则更大。结论:七种选择的过敏原(Dermatophagoides pteronyssinus,猫,草,桦树,橄榄花粉,链格孢属和克拉多孢菌)可用于流行病学研究中几乎所有敏感对象的鉴定。应在国际研究的标准小组中考虑纳入本地过敏原。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号